Targeted liposomal drug delivery system

Details Targeted liposomal drug delivery system Targeted liposomal drug delivery system

2007-01-30

2007-01-30

Woodward, Michael P. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

C424S400000, C424S078080, C424S078170

Reexamination Certificate

active

09313828

ABSTRACT:
A metal targeting complex which associates with a charged liposomal structure is provided. The metal targeting complex provides the targetability of the liposomal construct to the desired receptor sites of a warm-blooded host for therapy or diagnostic use.

REFERENCES:
patent: 3150160 (1964-09-01), Dexter
patent: 3373177 (1968-03-01), Young
patent: 3710795 (1973-01-01), Higuchi et al.
patent: 4016290 (1977-04-01), Rahman
patent: 4141911 (1979-02-01), Matsumoto et al.
patent: 4224179 (1980-09-01), Schneider
patent: 4310506 (1982-01-01), Baldeschwieler et al.
patent: 4328245 (1982-05-01), Yu et al.
patent: 4358603 (1982-11-01), Yu
patent: 4409239 (1983-10-01), Yu
patent: 4410545 (1983-10-01), Yu et al.
patent: 4603044 (1986-07-01), Geho et al.
patent: 4714607 (1987-12-01), Klaveness
patent: 4744989 (1988-05-01), Payne et al.
patent: 4797285 (1989-01-01), Barenholz et al.
patent: 4863896 (1989-09-01), Geho et al.
patent: 4866040 (1989-09-01), Stracher et al.
patent: 4891208 (1990-01-01), Janoff et al.
patent: 4921644 (1990-05-01), Lau et al.
patent: 4942036 (1990-07-01), Geho et al.
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 5000960 (1991-03-01), Wallach
patent: 5010073 (1991-04-01), Kappas et al.
patent: 5021200 (1991-06-01), Vanlerberghe et al.
patent: 5026558 (1991-06-01), Hwang
patent: 5104661 (1992-04-01), Lau
patent: 5128121 (1992-07-01), Berg et al.
patent: 5274082 (1993-12-01), Seri et al.
patent: 5288499 (1994-02-01), Janoff et al.
patent: 5330742 (1994-07-01), Deutsch et al.
patent: 5382421 (1995-01-01), White et al.
patent: 5387410 (1995-02-01), Bosworth et al.
patent: 5407660 (1995-04-01), Bosworth et al.
patent: 5435989 (1995-07-01), Presant et al.
patent: 5466467 (1995-11-01), Singh
patent: 5512294 (1996-04-01), Li et al.
patent: 5534241 (1996-07-01), Torchilin et al.
patent: 1564 (1982-07-01), None
patent: 165728 (1985-05-01), None
patent: 165728 (1985-05-01), None
patent: WO 88/00474 (1988-01-01), None
Hu et al., “Lord of the Rings: An Octadentate Lanthanum Pyrazolonate Cluster”, Angew. Chem. Int. Ed, 2000. 39(15) pp. 2745-2747.
“Cobalt” disclosure, downloaded from the World Wide Web at bilbo.chm.uri.edu/PeriodicTable/cobalt.htm.
Chemical Abstracts, vol. 108, 360, 108:201341J (JP62-221660).
Burns, H.D. et al.,J. Pharm Sci, “Improved Synthesis of N-(2,6-Dimethylphenyl-carbomoylmethyl)iminodiacetic Acid and Analogs”, vol. 67, No. 10, 1434-36 (Oct. 1978).
Gaizer, F. et al.Polyhedron, “Protonation and Complex Formation Equilibria of N-(Phenylcarbamoylmethyl)iminodiacetic Acid Derivatives . . . ”, vol. 11, No. 2, 257-64 (1992).

Affiliated with

Also associated with

Rating

Targeted liposomal drug delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Targeted liposomal drug delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted liposomal drug delivery system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3767663